SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-17-008092
Filing Date
2017-08-15
Accepted
2017-08-15 17:07:04
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 fate-s-3.htm S-3 666327
2 EX-4.4 fate-ex44_10.htm EX-4 390453
3 EX-4.5 fate-ex45_9.htm EX-4 400716
4 EX-5.1 fate-ex51_8.htm EX-5 23060
5 EX-23.1 fate-ex231_11.htm EX-23 2290
6 GRAPHIC g201708152027162899429.jpg GRAPHIC 4629
7 GRAPHIC g201708152027254488250.jpg GRAPHIC 25886
8 GRAPHIC g201708152027276789430.jpg GRAPHIC 4629
  Complete submission text file 0000950123-17-008092.txt   1532754
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-219987 | Film No.: 171034529
SIC: 2836 Biological Products, (No Diagnostic Substances)